319 related articles for article (PubMed ID: 29301505)
21. Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth.
Rovithi M; de Haas RR; Honeywell RJ; Poel D; Peters GJ; Griffioen AW; Verheul HM
J Exp Clin Cancer Res; 2016 Sep; 35(1):138. PubMed ID: 27604186
[TBL] [Abstract][Full Text] [Related]
22. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
[TBL] [Abstract][Full Text] [Related]
23. Technical Implications of the Chicken Embryo Chorioallantoic Membrane Assay to Elucidate Neuroblastoma Biology.
Patiño-Morales CC; Jaime-Cruz R; Ramírez-Fuentes TC; Villavicencio-Guzmán L; Salazar-García M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834193
[TBL] [Abstract][Full Text] [Related]
24. The chick embryo chorioallantoic membrane (CAM) assay.
Ribatti D
Reprod Toxicol; 2017 Jun; 70():97-101. PubMed ID: 27832950
[TBL] [Abstract][Full Text] [Related]
25. The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems.
Vargas A; Zeisser-Labouèbe M; Lange N; Gurny R; Delie F
Adv Drug Deliv Rev; 2007 Sep; 59(11):1162-76. PubMed ID: 17870202
[TBL] [Abstract][Full Text] [Related]
26. Applying the chicken embryo chorioallantoic membrane assay to study treatment approaches in urothelial carcinoma.
Skowron MA; Sathe A; Romano A; Hoffmann MJ; Schulz WA; van Koeveringe GA; Albers P; Nawroth R; Niegisch G
Urol Oncol; 2017 Sep; 35(9):544.e11-544.e23. PubMed ID: 28551413
[TBL] [Abstract][Full Text] [Related]
27. Digoxin inhibits neuroblastoma tumor growth in mice.
Svensson A; Azarbayjani F; Bäckman U; Matsumoto T; Christofferson R
Anticancer Res; 2005; 25(1A):207-12. PubMed ID: 15816540
[TBL] [Abstract][Full Text] [Related]
28. Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.
Duffy DJ; Krstic A; Halasz M; Schwarzl T; Konietzny A; Iljin K; Higgins DG; Kolch W
Genome Med; 2017 Feb; 9(1):15. PubMed ID: 28187790
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy-associated angiogenesis in neuroblastoma tumors.
Michaelis M; Hinsch N; Michaelis UR; Rothweiler F; Simon T; ilhelm Doerr HW; Cinatl J; Cinatl J
Am J Pathol; 2012 Apr; 180(4):1370-7. PubMed ID: 22285670
[TBL] [Abstract][Full Text] [Related]
30. Influence of LOX/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines.
Redova M; Chlapek P; Loja T; Zitterbart K; Hermanova M; Sterba J; Veselska R
Int J Mol Med; 2010 Feb; 25(2):271-80. PubMed ID: 20043138
[TBL] [Abstract][Full Text] [Related]
31. Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor.
Pastorino F; Loi M; Sapra P; Becherini P; Cilli M; Emionite L; Ribatti D; Greenberger LM; Horak ID; Ponzoni M
Clin Cancer Res; 2010 Oct; 16(19):4809-21. PubMed ID: 20702613
[TBL] [Abstract][Full Text] [Related]
32. Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat.
Ponthan F; Kogner P; Bjellerup P; Klevenvall L; Hassan M
Br J Cancer; 2001 Dec; 85(12):2004-9. PubMed ID: 11747346
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Adamson PC
Leukemia; 1994; 8 Suppl 3():S22-5. PubMed ID: 7808020
[TBL] [Abstract][Full Text] [Related]
34. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
[TBL] [Abstract][Full Text] [Related]
35. Effect of local aromatase inhibition in endometriosis using a new chick embryo chorioallantoic membrane model.
Pluchino N; Poppi G; Yart L; Marci R; Wenger JM; Tille JC; Cohen M
J Cell Mol Med; 2019 Aug; 23(8):5808-5812. PubMed ID: 31199588
[TBL] [Abstract][Full Text] [Related]
36. Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs.
Kue CS; Tan KY; Lam ML; Lee HB
Exp Anim; 2015; 64(2):129-38. PubMed ID: 25736707
[TBL] [Abstract][Full Text] [Related]
37. Combining peptide TNIIIA2 with all-
Otsuka K; Sasada M; Iyoda T; Nohara Y; Sakai S; Asayama T; Suenaga Y; Yokoi S; Higami Y; Kodama H; Fukai F
Am J Cancer Res; 2019; 9(2):434-448. PubMed ID: 30906641
[TBL] [Abstract][Full Text] [Related]
38. Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells.
Tanaka K; Tamiya-Koizumi K; Hagiwara K; Ito H; Takagi A; Kojima T; Suzuki M; Iwaki S; Fujii S; Nakamura M; Banno Y; Kannagi R; Tsurumi T; Kyogashima M; Murate T
J Biochem; 2012 Jun; 151(6):611-20. PubMed ID: 22451680
[TBL] [Abstract][Full Text] [Related]
39. The chorioallantoic membrane as a bio-barrier model for the evaluation of nanoscale drug delivery systems for tumour therapy.
Preis E; Schulze J; Gutberlet B; Pinnapireddy SR; Jedelská J; Bakowsky U
Adv Drug Deliv Rev; 2021 Jul; 174():317-336. PubMed ID: 33905805
[TBL] [Abstract][Full Text] [Related]
40. The chick embryo chorioallantoic membrane patient-derived xenograft (PDX) model.
Ribatti D
Pathol Res Pract; 2023 Mar; 243():154367. PubMed ID: 36774760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
